纤维蛋白胶市场规模、份额、成长分析（按产品类型、按技术、按应用、按最终用户、按地区）- 产业预测，2025 年至 2032 年

2023 年全球纤维蛋白胶市场规模为 5.929 亿美元，预计将从 2024 年的 6.3915 亿美元成长到 2032 年的 11.656 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.8%。

全球纤维蛋白胶市场正经历强劲成长，主要原因是人口老化导致外科手术增多，而老化使心血管疾病和癌症等需要外科手术治疗的慢性疾病更容易发生。随着手术变得越来越频繁和复杂，对有效止血剂的需求也日益增长，能够快速形成稳定血块、减少失血并加快恢復的纤维蛋白胶尤为受到青睐。此外，生物和重组DNA技术的进步正在生产出更安全、更有效的封闭剂，延长其保质期并降低其免疫抗原性风险，从而使得合成无病原体产品成为可能。这些创新正在改善黏附性、聚合速度和整体手术效果，从而拓展纤维蛋白胶在现代医学中的临床应用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

纤维蛋白胶市场规模（依产品类型及复合年增长率） （2025-2032）

• 市场概览
• 液体
  • 冷冻纤维蛋白胶
  • 冷冻纤维蛋白胶
• 修补
• 粉末
• 其他的

纤维蛋白胶市场规模（依技术及复合年增长率） （2025-2032）

• 市场概览
• 病毒灭活
• 自体血捐献
• 重组生产
• 其他的

纤维蛋白胶市场规模（按应用和复合年增长率） （2025-2032）

• 市场概览
• 整形外科
• 心血管外科
• 一般外科
• 移植手术
• 其他的

纤维蛋白胶市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 专科诊所
• 其他的

纤维蛋白胶市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Baxter International（USA）
• CSL Limited（Australia）
• Vivostat A/S（Denmark）
• Grifols, SA（Spain）
• Pfizer Inc.（USA）
• Stryker Corporation（USA）
• Hemarus（Australia）
• Asahi Kasei Corporation（Japan）
• Z-Medica（USA）
• Marquee Biosurgical（USA）
• Hualan Biological Engineering（China）
• CryoLife, Inc.（USA）
• Integra LifeSciences Corporation（USA）
• Becton, Dickinson and Company（USA）
• B. Braun SE（Germany）
• Corza Medical（USA/Switzerland）
• Cohera Medical（USA）
• Advanced Medical Solutions Group plc（UK）
• Ocular Therapeutix, Inc.（USA）
• MicroVal（France）

结论和建议

Global Fibrin Sealants Market size was valued at USD 592.9 million in 2023 and is poised to grow from USD 639.15 million in 2024 to USD 1165.6 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The global fibrin sealants market is experiencing robust growth, primarily driven by an increase in surgical procedures influenced by an aging population more prone to chronic diseases needing surgical care like cardiovascular issues and cancer. As surgeries become more frequent and complex, the demand for effective hemostatic agents rises, with fibrin sealants being favored for their ability to quickly form stable clots, reduce blood loss, and expedite recovery. Furthermore, advancements in biologic and recombinant DNA technologies are producing safer, more effective sealants with extended shelf lives and reduced immunogenic risks, enabling the production of synthetic and pathogen-free options. These innovations are enhancing adhesion, polymerization speed, and overall surgical outcomes, thereby broadening the clinical adoption of fibrin sealants in modern medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The global fibrin sealants market is significantly influenced by the increasing volume of surgical procedures taking place across the globe. This rise is largely attributed to the higher prevalence of chronic conditions such as cardiovascular diseases, cancer, and orthopedic issues. Consequently, there is a heightened demand for effective hemostatic agents, particularly fibrin sealants, which facilitate improved surgical outcomes. As more patients undergo surgeries to address these health concerns, the need for reliable and efficient solutions like fibrin sealants continues to expand, further propelling the growth of the market over time.

Restraints in the Global Fibrin Sealants Market

The global fibrin sealants market faces significant restraints due to regulatory challenges and prolonged approval timelines for fibrin sealant products. These obstacles slow down market expansion as the necessity for comprehensive clinical trials and adherence to regulations in various regions extends development periods. Consequently, this limits the introduction of new and innovative fibrin sealant solutions, potentially hindering access to advanced treatment options for healthcare providers and patients alike. As the market grapples with these regulatory complexities, the overall growth and evolution of fibrin sealant offerings may be significantly affected, impacting industry dynamics in the long run.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant surge, predominantly fueled by the rising preference for minimally invasive surgeries. As healthcare providers increasingly prioritize patient safety and quicker recovery times, fibrin sealants have emerged as a vital tool, enhancing surgical efficacy by reducing blood loss and promoting faster healing. This trend is particularly evident in critical fields such as cardiovascular and orthopedic surgery, where precision and rapid postoperative recovery are paramount. As a result, the demand for these biological adhesives is projected to escalate, positioning fibrin sealants as indispensable components in modern surgical practice, thereby shaping the future of surgical interventions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Liquid
  • Frozen fibrin sealants
  • Freeze dried fibrin sealants
• Patches
• Powder
• Others

Global Fibrin Sealants Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Viral Inactivation
• Autologous Donation
• Recombinant Production
• Others

Global Fibrin Sealants Market Size by Application & CAGR (2025-2032)

• Market Overview
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others

Global Fibrin Sealants Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Fibrin Sealants Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Baxter International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivostat A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemarus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marquee Biosurgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Medical (USA/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Therapeutix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVal (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations